Portrait of Sandra Wai
  • Telehealth visits
bch logo

Sandra Wai, MD

NeonatologyMedical Director, Severe Bronchopulmonary Dysplasia (BPD) Program, Oakland
Portrait of Sandra Wai
Portrait of Sandra Wai
bch logo

Sandra Wai, MD

NeonatologyMedical Director, Severe Bronchopulmonary Dysplasia (BPD) Program, Oakland
  • Telehealth visits

On this page

About me

Dr. Sandra Wai is a neonatologist who cares for critically ill newborns. She has special interests in bronchopulmonary dysplasia (a chronic lung disease of infants), pulmonary hypertension (high blood pressure in the arteries of the lungs), fetal growth restriction (a condition in which the gestating baby isn't a normal size because of slow growth), and growth and nutrition for newborns. She serves as medical directory of the Severe Bronchopulmonary Dysplasia (BPD) Program at UCSF Benioff Children's Hospital Oakland.

Wai earned her medical degree from Loma Linda University School of Medicine. She completed a residency in pediatrics at UCSF Benioff Children's Hospital Oakland, followed by a fellowship in neonatal-perinatal medicine at the University of Colorado School of Medicine.

Education & training

Board certification

  • Neonatal-Perinatal Medicine, American Board of Pediatrics/Neonatal-Perinatal
  • Pediatrics, American Board of Pediatrics

Fellowship

  • Neonatal-Perinatal Medicine, University of Colorado School of Medicine GME

Residency

  • Pediatrics, UCSF Benioff Children's Hospital--Oakland

Degree

  • MD, Loma Linda University School of Medicine

Academic Title

  • Health Sciences Clinical Professor

My expertise

My research

Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.